The co-owner, Chad Day, has been a part of the fundraising efforts for the six-year-old with Duchenne muscular dystrophy.

ABEL Motorsports driver Callum Hedge (photo) is trying to raise awareness and funds to combat muscular dystrophy in his ...

This year's Futures National Conference, hosted by CureDuchenne for the Duchenne and Becker MD communities, is scheduled to ...

Dyne Therapeutics (DYN) announced that the European Commission has granted orphan drug designation for DYNE-251 for the treatment of Duchenne ...

Dyne anticipates filing a Biologics License Application (BLA) submission for US accelerated approval in early 2026.

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as ...

For most parents, newborn screening tests are a barely perceptible safety net. But for the small minority whose babies get ...

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.

Jordan McLinn has been an advocate since childhood to add add Duchenne muscular dystrophy to Indiana’s newborn screening ...

John Brandsema, MD, a pediatric neurologist at Children’s Hospital of Philadelphia, speaks with Healio about the latest ...

In a difficult climate for capital raisings, biotechs are turning to loans backed by their expected research and development tax refunds.